The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 43 | — | 20.1x | Near average | |
Growth | 77 | 115.1% | 5.6% | Above average | |
Quality | 31 | -144.4% | 7.6% | Below average | |
Safety | 40 | -0.0x | 0.4x | Near average | |
Capital Return | 84 | — | 2.19% | Above average | |
Momentum | 26 | — | — | Below average | |
Sentiment | 31 | — | — | Below average |
Insmed Incorporated is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Insmed Incorporated shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Target prices for Insmed stock saw relative stability at an average of $213.11 over the past week, despite a slight decline of 2.03% compared to last month's levels ($217.53). A notable Dispersion is observed among analysts' estimates, with the range spanning between $160 and $269, reflecting a state of uncertainty regarding fair valuation even though the current price (106.24) is trading at a significant discount below the lowest target price.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.